Jennifer Kamocsay
General Counsel bei AKOYA BIOSCIENCES, INC.
Vermögen: 379 009 $ am 30.04.2024
Profil
Jennifer Kamocsay is currently the General Counsel at Akoya Biosciences, Inc. She previously worked as the Associate General Counsel at Progress Software Corp.
and as the General Counsel at Rubius Therapeutics, Inc. Ms. Kamocsay received an undergraduate degree from the University of California and a graduate degree from Northeastern University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AKOYA BIOSCIENCES INC
0,20% | 01.03.2024 | 99 217 ( 0,20% ) | 379 009 $ | 30.04.2024 |
Aktive Positionen von Jennifer Kamocsay
| Unternehmen | Position | Beginn |
|---|---|---|
| AKOYA BIOSCIENCES, INC. | General Counsel | 28.02.2023 |
Ehemalige bekannte Positionen von Jennifer Kamocsay
| Unternehmen | Position | Ende |
|---|---|---|
| PROGRESS SOFTWARE CORPORATION | Corporate Officer/Principal | - |
| RUBIUS THERAPEUTICS | General Counsel | - |
Ausbildung von Jennifer Kamocsay
| University of California | Undergraduate Degree |
| Northeastern University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AKOYA BIOSCIENCES, INC. | Health Technology |
| PROGRESS SOFTWARE CORPORATION | Technology Services |
| Private Unternehmen | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
